Risk factors for hospital admission among COVID-19 patients with diabetes A study from Saudi Arabia

被引:26
|
作者
Al Hayek, Ayman A. [1 ]
Robert, Asirvatham A. [1 ]
Bin Matar, Abdullah [2 ]
Algarni, Ali [2 ]
Alkubedan, Haneen [2 ]
Alharbi, Turki [2 ]
Al Amro, Afrah [3 ]
Alrashidi, Seham A. [2 ]
Al Dawish, Mohamed [1 ]
机构
[1] Prince Sultan Mil Med City, Dept Endocrinol & Diabet, Diabet Treatment Ctr, Riyadh, Saudi Arabia
[2] Prince Sultan Mil Med City, Dept Med, Riyadh, Saudi Arabia
[3] Prince Sultan Mil Med City, Dept Informat & Commun Technol, Riyadh, Saudi Arabia
关键词
COVID-19; diabetes mellitus; coronavirus; hospitalization; hospital admission;
D O I
10.15537/smj.2020.10.25419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To elucidate the risk factors for hospital admission among COVID-19 patients with type 2 diabetes mellitus (T2DM). Methods: This retrospective study was conducted at the Prince Sultan Military Medical City, Riyadh, Saudi Arabia between May 2020 and July 2020. Out of 7,260 COVID-19 patients, 920 were identified as T2DM. After the exclusion process, 806 patients with T2DM were included in this analysis. Patients' data were extracted from electronic medical records. A logistic regression model was performed to estimate the risk factors of hospital admission. Results: Of the total of 806 COVID-19 patients with T2DM, 48% were admitted in the hospital, 52% were placed under home isolation. Older age between 70-79 years (OR [odd ratio] 2.56; p=0.017), >= 80 years (OR 6.48; p=0.001) were significantly more likely to be hospitalized compared to <40 years. Similarly, patients with higher HbA1c level of >= 9% compared to <7%; (OR 1.58; p=0.047); patients with comorbidities such as, hypertension (OR 1.43; p=0.048), cardiovascular disease (OR 1.56; p=0.033), cerebrovascular disease (OR 2.38; p=0.016), chronic pulmonary disease (OR 1.51; p=0.018), malignancy (OR 2.45; p=0.025), chronic kidney disease (CKD) IIIa, IIIb, IV (OR 2.37; p=0.008), CKD V (OR 5.07; p=0.007) were significantly more likely to be hospitalized. Likewise, insulin-treated (OR 1.46; p=0.03) were more likely to require hospital admission compared to non-insulin treated patients. Conclusion: Among COVID-19 patients with diabetes, higher age, high HbA1c level, and presence of other comorbidities were found to be significant risk factors for the hospital admission.
引用
收藏
页码:1090 / 1097
页数:8
相关论文
共 50 条
  • [31] Factors Affecting COVID-19 Vaccination among the General Population in Saudi Arabia
    Al-Mansour, Khalid
    Alyahya, Saad
    AbuGazalah, Fouad
    Alabdulkareem, Khaled
    HEALTHCARE, 2021, 9 (09)
  • [32] Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia
    Alfallaj, Rayan
    AlSkait, Ghada
    Alamari, Nouf
    Alfawzan, Lama
    Abualgasem, Mohammed
    Alotaibi, Naif H. H.
    Sumaily, Ibrahim
    Alarifi, Ibrahim
    Alsaleh, Saad
    ALLERGY & RHINOLOGY, 2022, 13
  • [33] COVID-19 Precautionary Measures and Type 1 Diabetes Patients in Saudi Arabia
    Alguwaihes, Abdullah
    Al-Sofiani, Mohammed E.
    Alyusuf, Ebtihal
    Almutairi, Aeshah
    Ibrahim, Eman
    Albunyan, Sarah S.
    Alzahrani, Saad
    Hasanto, Rana
    Jammah, Anwar A.
    PRIMARY CARE DIABETES, 2021, 15 (05) : 793 - 798
  • [34] Prevalence of depression and its associated factors among patients with confirmed COVID-19 in Makkah, Saudi Arabia
    Alqurashi, Eid
    Aldobyany, Ahmad
    Touman, Abdelfattah
    Alqahtani, Abdullah
    Alsaggaf, Rajaa
    Alnashiwaaty, Omar
    Ghaleb, Nabil
    Mabar, Hanan
    Albanna, Amr S. S.
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [35] Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia
    Alzahrani, Hasan A.
    Wang, Dong
    Bakhotmah, Balkees A.
    Hu, Frank B.
    VASCULAR MEDICINE, 2014, 19 (02) : 103 - 111
  • [36] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Alqahtani, Saad M. A.
    Al Saglan, Naif S.
    AlShehry, Ali A.
    Hawan, Ali
    Dafalla, Badraltamam A. A.
    Mohamed, Nahid A. S.
    Kadasah, Ali S.
    Qureshi, Muhammad A.
    Al-Shahrani, Nourah A.
    Alfaifi, Abdulaziz S. Y.
    Alqahtani, Mohammed A.
    Alshafa, Fawwaz A.
    Alsalem, Ali A.
    Al-Imamah, Yahya A.
    Abdullah, Alahmari
    Alzulfah, Saad A. S.
    Mahmoud, Ibrahim M. A.
    Abuelhassan, Usama E.
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2023, 17 (01)
  • [37] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Saad M. A. alqahtani
    Naif S. Al Saglan
    Ali A. AlShehry
    Ali Hawan
    Badraltamam A. A.Dafalla
    Nahid A. S. Mohamed
    Ali S. Kadasah
    Muhammad A.Qureshi
    Nourah A. Al-Shahrani
    Abdulaziz S. Y. Alfaifi
    Mohammed A. Alqahtani
    Fawwaz A. Alshafa
    Ali A. Alsalem
    Yahya A. Al-Imamah
    Alahmari Abdullah
    Saad A. S. Alzulfah
    Ibrahim M. A. Mahmoud
    Usama E. Abuelhassan
    The Egyptian Journal of Bronchology, 17
  • [38] ICU admission of COVID-19 patients: Identification of risk factors
    Fouad, Shaimaa H.
    Allam, Mohamed Farouk
    Ibrahim, Sara
    Okba, Ahmed Ashraf
    Roman, Sylvia W.
    Hosny, Amr
    Moneer, Mayada
    EGYPTIAN JOURNAL OF ANAESTHESIA, 2021, 37 (01): : 202 - 207
  • [39] Survival, mortality, and related comorbidities among COVID-19 patients in Saudi Arabia A hospital-based retrospective cohort study
    AL-Ghamdi, Mohammad A.
    Al-Raddadi, Rajaa M.
    Ramadan, Iman K.
    Mirza, Ahmad A.
    Alsaab, Hanan A.
    Alobaidi, Hani F.
    Bin Hayd, Mohammed Y.
    SAUDI MEDICAL JOURNAL, 2022, 43 (08) : 915 - 926
  • [40] Risk Factors associated with COVID-19 Infection among Contacts of Index Cases in Saudi Arabia: A Case-Control Study
    Osama Kiram
    Shumukh Alhejaili
    Alwaleed Abdulhameed Alharbi
    Ammar Alrudayan
    Kurubaran Ganasegeran
    Mohammad A. Alharbi
    Mariam A. Alharbi
    Sami Abdo Radman Al-Dubai
    Dr. Sulaiman Al Habib Medical Journal, 2021, 3 (4) : 188 - 193